RECRUITING

Enhancing PTSD Treatment Outcomes by Improving Patient-Provider Communication

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this clinical trial is to learn whether existing treatments for posttraumatic stress disorder (PTSD) can be improved. Two treatments for PTSD, cognitive processing therapy (CPT) and prolonged exposure (PE) will be studied. CPT and PE are effective treatments that are widely available, but interventions are needed to improve patient outcomes in these treatments. The investigators have developed an Adjunctive Writing intervention for Amplifying Response and Engagement (AWARE), which was designed using health communication strategies to enhance CPT and PE by improving communication between patients and therapists about patients' experiences in treatment. This research will investigate whether adding AWARE to CPT and PE will lead to better treatment outcomes compared to CPT and PE provided as usual without AWARE. AWARE includes a brief writing task asking patients about their experiences in treatment, as well as guided therapist responses to improve patient-therapist communication about patients' experiences in treatment. In the first phase of the study (case series phase), CPT or PE with AWARE will be provided to four adults with PTSD to pilot test adding AWARE to CPT and PE, seek patient and provider feedback, and refine AWARE. The first four participants who enroll will be part of the case series and will receive CPT or PE with AWARE. Then, in the second phase of the study, the randomized controlled trial (RCT) phase, the investigators will enroll 50 more adults with PTSD who will be randomly assigned (like flipping a coin) to receive CPT/PE as usual or CPT/PE with AWARE. It is expected that 25 participants will be randomized to CPT/PE with AWARE and 25 participants will be randomized to receive CPT/PE provided as usual. The goals of the RCT phase are to study whether AWARE is acceptable to patients, whether it is feasible to add AWARE to CPT and PE, and whether adding AWARE to CPT and PE improves patient-therapist communication and treatment outcomes compared to CPT/PE as usual.

Official Title

Enhancing PTSD Treatment Outcomes by Improving Patient-Provider Communication

Quick Facts

Study Start:2025-01-31
Study Completion:2028-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06088303

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of PTSD
  2. * Stable on psychiatric medications for at least 4 weeks
  1. * Current unstable bipolar disorder
  2. * Current psychosis
  3. * Current active suicidal or homicidal ideation with intent or plan
  4. * Current severe substance use that warrants immediate medical attention
  5. * Current trauma-focused treatment
  6. * Significant cognitive impairment that would prevent engagement in assessments and therapy (e.g., advanced dementia, severe traumatic brain injury).

Contacts and Locations

Study Contact

Elizabeth Alpert, PhD
CONTACT
857-364-6190
elizabeth.alpert@va.gov

Principal Investigator

Elizabeth Alpert, PhD
PRINCIPAL_INVESTIGATOR
National Center for PTSD at VA Boston Healthcare System, BU School of Medicine, Psychiatry

Study Locations (Sites)

National Center for PTSD at VA Boston Healthcare System
Boston, Massachusetts, 02130
United States

Collaborators and Investigators

Sponsor: Boston University

  • Elizabeth Alpert, PhD, PRINCIPAL_INVESTIGATOR, National Center for PTSD at VA Boston Healthcare System, BU School of Medicine, Psychiatry

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-31
Study Completion Date2028-12-31

Study Record Updates

Study Start Date2025-01-31
Study Completion Date2028-12-31

Terms related to this study

Keywords Provided by Researchers

  • Posttraumatic stress disorder
  • Cognitive processing therapy
  • Prolonged exposure
  • Adjunctive writing for amplifying response and engagement
  • Health communication
  • Patient-provider communication

Additional Relevant MeSH Terms

  • Stress Disorders, Post-Traumatic